Sidley represented San Francisco, California-based Tricida, Inc. in its $222 million initial public offering (IPO) of common stock. Tricida is a pharmaceutical company focused on the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
